LMAT logo

LeMaitre Vascular (LMAT) Cash From Operations

Annual CFO

$36.75 M
+$11.37 M+44.81%

31 December 2023

LMAT Cash From Operations Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CFO

$14.25 M
+$4.62 M+48.01%

30 September 2024

LMAT Quarterly CFO Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CFO

$39.69 M
+$2.42 M+6.50%

30 September 2024

LMAT TTM CFO Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

LMAT Cash From Operations Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+44.8%+20.5%+31.9%
3 y3 years+5.6%+1.2%-10.2%
5 y5 years+88.4%+218.7%+161.9%

LMAT Cash From Operations High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+44.8%at high+525.1%-10.2%+73.0%
5 y5 yearsat high+159.2%at high+1098.2%-10.3%+179.9%
alltimeall timeat high+2112.7%at high+427.6%-10.3%+1029.9%

LeMaitre Vascular Cash From Operations History

DateAnnualQuarterlyTTM
Sept 2024
-
$14.25 M(+48.0%)
$39.69 M(+6.5%)
June 2024
-
$9.63 M(+89.8%)
$37.27 M(-5.8%)
Mar 2024
-
$5.07 M(-52.8%)
$39.54 M(+7.6%)
Dec 2023
$36.75 M(+44.8%)
$10.75 M(-9.1%)
$36.75 M(+22.2%)
Sept 2023
-
$11.82 M(-0.7%)
$30.08 M(+17.5%)
June 2023
-
$11.90 M(+422.3%)
$25.60 M(+11.6%)
Mar 2023
-
$2.28 M(-44.1%)
$22.95 M(-9.6%)
Dec 2022
$25.38 M(-27.7%)
$4.08 M(-44.5%)
$25.38 M(-3.7%)
Sept 2022
-
$7.34 M(-20.6%)
$26.36 M(-20.3%)
June 2022
-
$9.25 M(+96.3%)
$33.09 M(-1.9%)
Mar 2022
-
$4.71 M(-6.8%)
$33.74 M(-3.9%)
Dec 2021
$35.10 M(+0.9%)
$5.06 M(-64.1%)
$35.10 M(-20.6%)
Sept 2021
-
$14.07 M(+42.2%)
$44.20 M(-0.1%)
June 2021
-
$9.90 M(+62.9%)
$44.23 M(+11.5%)
Mar 2021
-
$6.07 M(-57.1%)
$39.69 M(+14.0%)
Dec 2020
$34.80 M(+145.4%)
$14.15 M(+0.3%)
$34.80 M(+32.6%)
Sept 2020
-
$14.11 M(+163.9%)
$26.24 M(+58.1%)
June 2020
-
$5.35 M(+349.7%)
$16.60 M(+6.5%)
Mar 2020
-
$1.19 M(-78.7%)
$15.59 M(+9.9%)
Dec 2019
$14.18 M(-27.3%)
$5.59 M(+25.1%)
$14.18 M(-6.4%)
Sept 2019
-
$4.47 M(+3.1%)
$15.16 M(+1.1%)
June 2019
-
$4.33 M(-2079.0%)
$14.99 M(-3.5%)
Mar 2019
-
-$219.00 K(-103.3%)
$15.54 M(-20.4%)
Dec 2018
$19.51 M(-14.7%)
$6.57 M(+52.5%)
$19.51 M(-1.0%)
Sept 2018
-
$4.31 M(-11.6%)
$19.70 M(-16.5%)
June 2018
-
$4.88 M(+30.0%)
$23.59 M(-2.3%)
Mar 2018
-
$3.75 M(-44.6%)
$24.14 M(+5.6%)
Dec 2017
$22.87 M(+35.3%)
$6.77 M(-17.4%)
$22.87 M(+12.7%)
Sept 2017
-
$8.20 M(+51.1%)
$20.29 M(+10.0%)
June 2017
-
$5.42 M(+119.1%)
$18.44 M(+1.8%)
Mar 2017
-
$2.48 M(-41.0%)
$18.11 M(+7.2%)
Dec 2016
$16.90 M(+47.7%)
$4.19 M(-34.0%)
$16.90 M(+1.6%)
Sept 2016
-
$6.35 M(+24.7%)
$16.63 M(+14.8%)
June 2016
-
$5.09 M(+304.9%)
$14.49 M(+9.0%)
Mar 2016
-
$1.26 M(-67.9%)
$13.30 M(+16.2%)
Dec 2015
$11.44 M
$3.92 M(-6.8%)
$11.44 M(+12.2%)
Sept 2015
-
$4.21 M(+7.9%)
$10.20 M(+14.8%)
June 2015
-
$3.90 M(-750.3%)
$8.88 M(+34.5%)
DateAnnualQuarterlyTTM
Mar 2015
-
-$600.00 K(-122.4%)
$6.60 M(+19.8%)
Dec 2014
$5.51 M(+2.3%)
$2.68 M(-7.4%)
$5.51 M(+31.7%)
Sept 2014
-
$2.90 M(+78.4%)
$4.19 M(+13.7%)
June 2014
-
$1.62 M(-196.1%)
$3.68 M(-9.0%)
Mar 2014
-
-$1.69 M(-224.6%)
$4.04 M(-24.9%)
Dec 2013
$5.39 M(+14.1%)
$1.36 M(-43.3%)
$5.39 M(+20.8%)
Sept 2013
-
$2.39 M(+20.3%)
$4.46 M(+13.4%)
June 2013
-
$1.99 M(-674.3%)
$3.93 M(-1.5%)
Mar 2013
-
-$346.00 K(-181.0%)
$3.99 M(-15.5%)
Dec 2012
$4.72 M(+49.0%)
$427.00 K(-77.1%)
$4.72 M(+18.3%)
Sept 2012
-
$1.86 M(-8.9%)
$3.99 M(-11.3%)
June 2012
-
$2.04 M(+429.8%)
$4.50 M(-24.6%)
Mar 2012
-
$386.00 K(-227.4%)
$5.97 M(+88.3%)
Dec 2011
$3.17 M(-55.0%)
-$303.00 K(-112.8%)
$3.17 M(-28.6%)
Sept 2011
-
$2.38 M(-32.4%)
$4.44 M(-5.3%)
June 2011
-
$3.51 M(-245.5%)
$4.69 M(+22.8%)
Mar 2011
-
-$2.41 M(-349.1%)
$3.82 M(-45.8%)
Dec 2010
$7.05 M(+29.6%)
$969.00 K(-63.1%)
$7.05 M(-12.4%)
Sept 2010
-
$2.62 M(-0.7%)
$8.05 M(-6.3%)
June 2010
-
$2.64 M(+222.5%)
$8.59 M(+0.3%)
Mar 2010
-
$819.00 K(-58.4%)
$8.56 M(+57.4%)
Dec 2009
$5.44 M(+836.3%)
$1.97 M(-37.7%)
$5.44 M(-8.4%)
Sept 2009
-
$3.16 M(+21.0%)
$5.94 M(+45.3%)
June 2009
-
$2.61 M(-213.4%)
$4.09 M(+55.7%)
Mar 2009
-
-$2.31 M(-193.4%)
$2.62 M(+351.6%)
Dec 2008
$581.00 K(-131.8%)
$2.47 M(+88.4%)
$581.00 K(-124.6%)
Sept 2008
-
$1.31 M(+13.7%)
-$2.36 M(-25.9%)
June 2008
-
$1.15 M(-126.5%)
-$3.18 M(-25.4%)
Mar 2008
-
-$4.35 M(+825.3%)
-$4.27 M(+133.7%)
Dec 2007
-$1.83 M(+247.1%)
-$470.00 K(-196.9%)
-$1.83 M(+31.6%)
Sept 2007
-
$485.00 K(+634.8%)
-$1.39 M(-34.8%)
June 2007
-
$66.00 K(-103.5%)
-$2.13 M(-31.1%)
Mar 2007
-
-$1.91 M(+5859.4%)
-$3.09 M(+487.5%)
Dec 2006
-$526.00 K(-56.2%)
-$32.00 K(-87.5%)
-$526.00 K(+6.5%)
Sept 2006
-
-$257.00 K(-71.3%)
-$494.00 K(+108.4%)
June 2006
-
-$894.00 K(-236.1%)
-$237.00 K(-136.1%)
Mar 2006
-
$657.00 K
$657.00 K
Dec 2005
-$1.20 M(-171.5%)
-
-
Dec 2004
$1.68 M
-
-

FAQ

  • What is LeMaitre Vascular annual cash flow from operations?
  • What is the all time high annual CFO for LeMaitre Vascular?
  • What is LeMaitre Vascular annual CFO year-on-year change?
  • What is LeMaitre Vascular quarterly cash flow from operations?
  • What is the all time high quarterly CFO for LeMaitre Vascular?
  • What is LeMaitre Vascular quarterly CFO year-on-year change?
  • What is LeMaitre Vascular TTM cash flow from operations?
  • What is the all time high TTM CFO for LeMaitre Vascular?
  • What is LeMaitre Vascular TTM CFO year-on-year change?

What is LeMaitre Vascular annual cash flow from operations?

The current annual CFO of LMAT is $36.75 M

What is the all time high annual CFO for LeMaitre Vascular?

LeMaitre Vascular all-time high annual cash flow from operations is $36.75 M

What is LeMaitre Vascular annual CFO year-on-year change?

Over the past year, LMAT annual cash flow from operations has changed by +$11.37 M (+44.81%)

What is LeMaitre Vascular quarterly cash flow from operations?

The current quarterly CFO of LMAT is $14.25 M

What is the all time high quarterly CFO for LeMaitre Vascular?

LeMaitre Vascular all-time high quarterly cash flow from operations is $14.25 M

What is LeMaitre Vascular quarterly CFO year-on-year change?

Over the past year, LMAT quarterly cash flow from operations has changed by +$2.42 M (+20.49%)

What is LeMaitre Vascular TTM cash flow from operations?

The current TTM CFO of LMAT is $39.69 M

What is the all time high TTM CFO for LeMaitre Vascular?

LeMaitre Vascular all-time high TTM cash flow from operations is $44.23 M

What is LeMaitre Vascular TTM CFO year-on-year change?

Over the past year, LMAT TTM cash flow from operations has changed by +$9.61 M (+31.93%)